Research Article
Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers
Table 1
Study characteristics of mTOR rs2295080 T/G and rs1883965 G/A variants in the current analysis.
| Author | Year | Origin | Cancer | Ethnicity | Type | Source of control | Case | Control | Case | Control | HWE | Method | rs2295080 T/G | GG | GT | TT | GG | GT | TT |
| Cao | 2012 | China | KIRC | East Asian | Urinary cancer | Hospital-based | 710 | 760 | 38 | 218 | 454 | 45 | 277 | 438 | 0.891 | TaqMan | Chen | 2012 | China | PRAD | East Asian | Urinary cancer | Hospital-based | 666 | 708 | 28 | 209 | 429 | 36 | 259 | 413 | 0.573 | TaqMan | Huang | 2012 | China | ALL | East Asian | Blood cancer | Hospital-based | 417 | 554 | 23 | 140 | 254 | 21 | 180 | 353 | 0.549 | TaqMan | Li | 2013 | China | PRAD | East Asian | Urinary cancer | Population-based | 1004 | 1051 | 40 | 311 | 653 | 52 | 382 | 617 | 0.468 | TaqMan | Xu | 2013 | China | GCA | East Asian | Digestive cancer | Hospital-based | 753 | 854 | 25 | 246 | 482 | 52 | 305 | 497 | 0.569 | TaqMan | Wang | 2015 | China | GCA | East Asian | Digestive cancer | Hospital-based | 1002 | 1003 | 40 | 394 | 568 | 41 | 355 | 607 | 0.221 | TaqMan | Xu | 2015 | China | CRC | East Asian | Digestive cancer | Hospital-based | 737 | 777 | 30 | 225 | 482 | 45 | 273 | 459 | 0.602 | TaqMan | Zhao | 2015 | China | ALL | East Asian | Blood cancer | Hospital-based | 133 | 296 | 15 | 50 | 68 | 12 | 111 | 173 | <0.001 | PCR-RFLP | Zhao | 2015 | China | AML | East Asian | Blood cancer | Hospital-based | 47 | 296 | 6 | 14 | 27 | 12 | 111 | 173 | <0.001 | PCR-RFLP | Zhu | 2015 | China | ESCC | East Asian | Digestive cancer | Population-based | 1113 | 1113 | 49 | 390 | 674 | 49 | 362 | 702 | 0.788 | TaqMan | Zhang | 2015 | China | KIRC | East Asian | Urinary cancer | Hospital-based | 710 | 760 | 38 | 218 | 454 | 45 | 277 | 438 | 0.891 | TaqMan | Zhao | 2016 | China | Breast | East Asian | Breast cancer | Hospital-based | 560 | 583 | 12 | 197 | 351 | 26 | 212 | 345 | 0.358 | Sequenom | Liu | 2017 | China | PRAD | East Asian | Urinary cancer | Hospital-based | 413 | 807 | 32 | 145 | 236 | 37 | 316 | 454 | 0.052 | TaqMan | Wen | 2017 | China | TCA | East Asian | Others | Population-based | 560 | 500 | 24 | 170 | 366 | 29 | 176 | 295 | 0.686 | TaqMan | Zhao | 2017 | China | GCA | East Asian | Digestive cancer | Population-based | 283 | 271 | 15 | 90 | 178 | 11 | 86 | 174 | 0.927 | TaqMan | Qi | 2017 | China | GCA | East Asian | Digestive cancer | Hospital-based | 574 | 912 | 101 | 279 | 194 | 174 | 441 | 297 | 0.651 | TaqMan | Bizhani | 2018 | Iran | BLCA | West Asian | Urinary cancer | Population-based | 235 | 254 | 80 | 90 | 65 | 152 | 76 | 26 | 0.001 | PCR-RFLP | Chen | 2019 | China | Breast | East Asian | Breast cancer | Population-based | 530 | 480 | 19 | 201 | 310 | 37 | 198 | 245 | 0.730 | TaqMan |
| rs1883965 G/A | | | | | | | AA | AG | GG | AA | AG | GG | | | He | 2013 | China | GCA | East Asian | Digestive cancer | Population-based | 1125 | 1196 | 10 | 188 | 927 | 6 | 165 | 1025 | 0.817 | TaqMan | Zhu | 2013 | China | ESCC | East Asian | Digestive cancer | Population-based | 1123 | 1121 | 6 | 209 | 908 | 7 | 174 | 940 | 0.732 | TaqMan | Li | 2013 | China | PRAD | East Asian | Urinary cancer | Population-based | 1004 | 1051 | 8 | 153 | 843 | 7 | 154 | 890 | 0.904 | TaqMan | Liu | 2014 | China | Liver | East Asian | Digestive cancer | Hospital-based | 1048 | 1052 | 2 | 165 | 881 | 10 | 160 | 882 | 0.365 | TaqMan |
|
|
ALL: acute lymphoblastic leukemia; BLCA: bladder cancer; CRC: colorectal cancer; AML: acute myeloid leukemia; ESCC: esophageal squamous cell carcinoma; GCA: gastric cancer; HWE: Hardy-Weinberg equilibrium of control; PRAD: prostate cancer; TCA: thyroid cancer; KIRC: kidney renal clear cell carcinoma.
|